Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Erwin

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Nuclear Medicine Communications|March 22, 2001
Correlation of marrow dose estimates based on serial pretreatment radiopharmaceutical imaging and blood data with actual marrow toxicity in anti-CD20 yttrium-90 monoclonal antibody radioimmunotherapy of non-Hodgkin's B-cell lymphomaW D Erwin, S M Spies, M E Kelly, et al.
Nuclear Medicine Communications|July 1, 1993
Body and blood clearance and marrow radiation dose of 131I-Lym-1 in patients with B-cell malignanciesG L DeNardo, M A Mahe, S J DeNardo, et al.
European Journal of Nuclear Medicine|June 1, 1996
Validation of a knowledge-based boundary detection algorithm: a multicenter studyM W Groch, W D Erwin, P H Murphy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1996
Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodiesD A DeNardo, G L DeNardo, A Yuan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Planar imaging versus gated blood-pool SPECT for the assessment of ventricular performance: a multicenter studyM W Groch, E G DePuey, A C Belzberg, et al.
Critical Reviews in Oncology/Hematology|June 22, 2001
Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphomaG A Wiseman, C A White, R B Sparks, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Nuclear Medicine Communications|March 22, 2001
Correlation of marrow dose estimates based on serial pretreatment radiopharmaceutical imaging and blood data with actual marrow toxicity in anti-CD20 yttrium-90 monoclonal antibody radioimmunotherapy of non-Hodgkin's B-cell lymphomaW D Erwin, S M Spies, M E Kelly, et al.
Nuclear Medicine Communications|July 1, 1993
Body and blood clearance and marrow radiation dose of 131I-Lym-1 in patients with B-cell malignanciesG L DeNardo, M A Mahe, S J DeNardo, et al.
European Journal of Nuclear Medicine|June 1, 1996
Validation of a knowledge-based boundary detection algorithm: a multicenter studyM W Groch, W D Erwin, P H Murphy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1996
Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodiesD A DeNardo, G L DeNardo, A Yuan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Planar imaging versus gated blood-pool SPECT for the assessment of ventricular performance: a multicenter studyM W Groch, E G DePuey, A C Belzberg, et al.
Critical Reviews in Oncology/Hematology|June 22, 2001
Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphomaG A Wiseman, C A White, R B Sparks, et al.
Pageof 4